MA49019A - Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation - Google Patents

Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation

Info

Publication number
MA49019A
MA49019A MA049019A MA49019A MA49019A MA 49019 A MA49019 A MA 49019A MA 049019 A MA049019 A MA 049019A MA 49019 A MA49019 A MA 49019A MA 49019 A MA49019 A MA 49019A
Authority
MA
Morocco
Prior art keywords
new sigma
receiver modulators
modulators
receiver
sigma
Prior art date
Application number
MA049019A
Other languages
English (en)
French (fr)
Inventor
Benjamin E Blass
Kevin M Blattner
Daniel J Canney
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of MA49019A publication Critical patent/MA49019A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA049019A 2017-03-21 2018-03-15 Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation MA49019A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762474277P 2017-03-21 2017-03-21

Publications (1)

Publication Number Publication Date
MA49019A true MA49019A (fr) 2020-02-05

Family

ID=63585700

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049019A MA49019A (fr) 2017-03-21 2018-03-15 Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation

Country Status (5)

Country Link
US (3) US10961249B2 (cg-RX-API-DMAC7.html)
EP (1) EP3600290B1 (cg-RX-API-DMAC7.html)
JP (2) JP7365237B2 (cg-RX-API-DMAC7.html)
MA (1) MA49019A (cg-RX-API-DMAC7.html)
WO (1) WO2018175188A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10858368B2 (en) 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
JP7365237B2 (ja) * 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション シグマ-2受容体の新規調節物質およびその使用方法
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS
WO2019217890A1 (en) * 2018-05-11 2019-11-14 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
GB201809295D0 (en) 2018-06-06 2018-07-25 Institute Of Cancer Res Royal Cancer Hospital Lox inhibitors
CN112010859B (zh) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途
AU2023323878A1 (en) * 2022-08-11 2025-01-30 Remynd N.V. (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
GB0419192D0 (en) * 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
JP2010509402A (ja) * 2006-11-13 2010-03-25 キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド A1アデノシン受容体のアロステリック調節剤
US8148408B2 (en) * 2008-05-09 2012-04-03 Abbott Laboratories Selective substituted pyridine ligands for neuronal nicotinic receptors
US8697888B2 (en) * 2012-01-06 2014-04-15 Vanderbilt University Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
WO2014085413A1 (en) 2012-11-28 2014-06-05 Temple University - Of The Commonwealth System Of Higher Education Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
EP2928474B1 (en) 2012-12-07 2018-11-14 ChemoCentryx, Inc. Diazole lactams
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US9809545B2 (en) * 2013-03-27 2017-11-07 Merck Sharp & Dohme Corp. Factor XIa inhibitors
KR20160098506A (ko) * 2013-12-20 2016-08-18 라보라토리오스 델 드라. 에스테브.에스.에이. 통증에 대한 다양한 활성을 갖는 피페라진 유도체
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
CR20170118A (es) * 2014-10-08 2017-07-10 Hoffmann La Roche Derivados espirodiamina como inhibidores de la aldosterona sintasa
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
US20180221365A1 (en) * 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
US10858368B2 (en) * 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS
JP7365237B2 (ja) 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション シグマ-2受容体の新規調節物質およびその使用方法
WO2019217890A1 (en) 2018-05-11 2019-11-14 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
CN115003675A (zh) 2019-11-13 2022-09-02 英联邦高等教育系统坦普尔大学 作为5-羟色胺受体7调节剂的新型官能化内酰胺及其使用方法
MX2022005819A (es) 2019-11-13 2022-08-16 Univ Temple Nuevas lactonas funcionalizadas como moduladores del receptor 7 de 5-hidroxitriptamina y su método de uso.

Also Published As

Publication number Publication date
US20210363145A1 (en) 2021-11-25
JP7365237B2 (ja) 2023-10-19
JP7781122B2 (ja) 2025-12-05
JP2020511506A (ja) 2020-04-16
US20200039985A1 (en) 2020-02-06
US20240300954A1 (en) 2024-09-12
EP3600290C0 (en) 2025-06-04
EP3600290A1 (en) 2020-02-05
US10961249B2 (en) 2021-03-30
WO2018175188A1 (en) 2018-09-27
EP3600290A4 (en) 2020-08-12
JP2023168623A (ja) 2023-11-24
US12577251B2 (en) 2026-03-17
US11820774B2 (en) 2023-11-21
EP3600290B1 (en) 2025-06-04

Similar Documents

Publication Publication Date Title
EP3344806A4 (en) GLYCANARRAYS AND METHOD OF USE
EP3310305A4 (en) BRANCHED AORTIC TRANSPLANT AND METHOD OF USE THEREOF
EP3603543A4 (en) TOURNIQUET AND HEMOSTATIC PROCEDURE
EP3541790A4 (en) NEW MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD FOR USE THEREOF
EP3368404A4 (en) SEPARATE TOWER JOINT ARRANGEMENT AND METHOD FOR USE THEREOF
EP3303634A4 (en) CAS9 VARIANTS AND METHOD FOR USE THEREOF
MA45996A (fr) Variants d'endonucléase de homing du récepteur alpha de l'il-10, compositions et méthodes d'utilisation associées
EP3385835A4 (en) METHOD AND DEVICE FOR CONFIGURING A ACCELERATOR
EP3119761C0 (en) ANTI-AMYLOID AGENTS AND METHODS OF USE THEREOF
EP3371930A4 (en) METHOD AND DEVICE FOR SECURE AGGREGATED EVENT MESSAGE
EP3368663A4 (en) VIRUS-FREE CELL LINES AND METHOD FOR THE MANUFACTURE THEREOF
EP3632933A4 (en) Novel anti-cd40 antibodies and use thereof
EP3816282A4 (en) LUCIFERIN BIOSYNTHETIC ENZYMES AND THEIR USE
EP3638037A4 (en) INSECTICIDAL PROTEINS FROM PLANTS AND METHOD OF USING THEM
EP3073705A4 (en) CHANNEL MANUFACTURING METHOD AND DEVICE
EP3604367A4 (en) BLOCK CO-POLYMER AND METHOD FOR MANUFACTURING A BLOCK CO-POLYMER
EP3101933A4 (en) PHYSICAL CELL IDENTIFIER ASSIGNMENT METHOD AND DEVICE
EP3852015A4 (en) SURGICAL ACCELERATOR AND COMPRESSION PROCEDURES
EP3411046A4 (en) RAPAGLUTINES, NOVEL GLUT INHIBITORS AND USES THEREOF
EP3478052A4 (en) INSECTICIDE PROTEINS FROM PLANTS AND METHODS FOR THEIR USE
EP3334522A4 (en) ADSORPTION AGENTS AND METHOD FOR THE PRODUCTION AND USE OF ADSORPTION AGENTS
MA50440A (fr) Imidazopyridinamides substituées et leur utilisation
EP3684437A4 (en) METHOD AND DEVICE FOR FILTERING
EP3528631A4 (en) PLANT INSECTICIDE PROTEINS AND METHOD FOR USE THEREOF
MA44087A (fr) Immunothérapie basée sur la listéria et ses méthodes d'utilisation